Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial.
about
Nasal high flow reduces dead spaceUse of Nasal High Flow in Stable COPD: Rationale and Physiology.Why High-Intensity NPPV is Favourable to Low-Intensity NPPV: Clinical and Physiological Reasons.Invited Review Series Introduction.Evaluation by various methods of the physiological mechanism of a high-flow nasal cannula (HFNC) in healthy volunteers.Effect of high-flow nasal therapy during acute aerobic exercise in patients with chronic obstructive pulmonary disease after exacerbation: protocol for a randomised, controlled, cross-over trial.Nasal high-flow oxygen therapy improves arterial oxygenation during one-lung ventilation in non-intubated thoracoscopic surgery.Effectiveness of nasal highflow in hypercapnic COPD patients is flow and leakage dependent.Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross-over trial.NHF and hypercapnia: How brief can you look?Physiological effects of titrated oxygen via nasal high-flow cannulae in COPD exacerbations: A randomized controlled cross-over trial.Carbon dioxide washout during high flow nasal cannula versus nasal CPAP support: An in vitro study.What every intensivist should know about using high-flow nasal oxygen for critically ill patients.Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure.Comparison of high flow nasal cannula oxygen and conventional oxygen therapy on ventilatory support duration during acute-on-chronic respiratory failure: study protocol of a multicentre, randomised, controlled trial. The 'HIGH-FLOW ACRF' studyHigh-flow nasal oxygen versus noninvasive ventilation in adult patients with cystic fibrosis: a randomized crossover physiological studyHigh-flow nasal cannula oxygen therapy decreases postextubation neuroventilatory drive and work of breathing in patients with chronic obstructive pulmonary disease
P2860
Q30837047-D74DDD77-2268-45DE-9F6A-4F241B98764BQ39274949-E328B30C-7898-45D5-9BEF-B00F15CBCCC8Q39298717-DF552588-76A5-4157-8ACF-991A1426C0D3Q39332645-AE3D2293-2B99-4CD7-AC71-07130221E154Q42676987-B70958F5-2BFB-43BC-A0E3-6F06D4033C8CQ42676994-ED405C8B-CE12-4A2C-A94E-8BA1F11798ABQ47219781-C76CDDE8-9809-46D0-A804-2617976E954FQ47647952-D3681B21-968C-493D-9030-B3C5A9FFFA62Q47764608-720A27FC-1AFC-454C-AD1B-4397DBFF3B72Q47869753-5D677FE4-49B0-4F0D-8E9A-FBBBAC8B324CQ47902290-4EE9CED4-1041-49ED-A987-F1AFDB9FF2A3Q47980948-FD9E7FA4-9796-4372-8AF1-FFD9A97BA3DFQ50051688-F7BB2BFC-C1A1-49EF-8841-1EDB7A039997Q55346426-BF736F56-CD75-4EF5-90E0-0AA5CD700E16Q58718387-CF4351C5-5CFC-47E8-8165-AD905DD74218Q58763564-203959AF-548C-4C41-9908-ADDF9A73EA9AQ58803082-82C9B997-E49F-4E60-A9D2-F22CB2873482
P2860
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@en
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@nl
type
label
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@en
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@nl
prefLabel
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@en
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@nl
P2093
P2860
P1433
P1476
Nasal high flow oxygen therapy ...... a randomised crossover trial.
@en
P2093
Amy J Spooner
John F Fraser
Kimble R Dunster
P2860
P304
P356
10.1136/THORAXJNL-2015-207962
P407
P577
2016-03-25T00:00:00Z